Optos has announced a dual milestone achievement of over 25,000 devices installed worldwide, and a collection of 2,500 clinical and peer-reviewed studies spanning 235 disease states. The milestone demonstrates the more than 30 years of positive impact the company has had on the standard of retinal imaging technology and advancement of patient care.